
Sign up to save your podcasts
Or


To mark our 50th episode, host Ross Katz brings back three visionary leaders—Dave Johnson (Dash Bio), Wolfgang Halter (Merck Life Science), and Jacob Oppenheim (RAVen)—together for a reflection on the evolution of biotech. They unpack the realities behind AI hype, the future of data-driven innovation, and what’s really changing in drug development.
What You'll Learn in This Episode:
>> Where real innovation is emerging across startups, big tech, and academia
>> The biggest misconceptions about data in biotech—and why they persist
>> What it takes to build trust in AI-powered biotech tools
>> Why progress in biotech depends as much on execution as it does on breakthroughs
>> How industry veterans see the future of automation, regulation, and global competition
Meet Our Guests
Dave Johnson is CEO and Co-Founder of Dash Bio and former Chief Data & AI Officer at Moderna. He’s pioneering automation in clinical bioanalysis to accelerate drug development.
Wolfgang Halter leads Data Science at Merck Life Science, developing tools like BayBE to optimize R&D through smarter data modeling and open-source innovation.
Jacob Oppenheim is a Venture Partner at RAVen and co-founder of Fresnel. With a PhD in Biological Physics, he champions the transition to digital-native biopharma.
About The Host
Ross Katz is Principal and Data Science Lead at CorrDyn. Ross specializes in building intelligent data systems that empower biotech and healthcare organizations to extract insights and drive innovation.
Connect with Our Guest:
Connect with Us:
Sponsored by…
This episode is brought to you by CorrDyn, the leader in data-driven solutions for biotech and healthcare. Discover how CorrDyn is helping organizations turn data into breakthroughs at CorrDyn.
By CorrDyn5
1010 ratings
To mark our 50th episode, host Ross Katz brings back three visionary leaders—Dave Johnson (Dash Bio), Wolfgang Halter (Merck Life Science), and Jacob Oppenheim (RAVen)—together for a reflection on the evolution of biotech. They unpack the realities behind AI hype, the future of data-driven innovation, and what’s really changing in drug development.
What You'll Learn in This Episode:
>> Where real innovation is emerging across startups, big tech, and academia
>> The biggest misconceptions about data in biotech—and why they persist
>> What it takes to build trust in AI-powered biotech tools
>> Why progress in biotech depends as much on execution as it does on breakthroughs
>> How industry veterans see the future of automation, regulation, and global competition
Meet Our Guests
Dave Johnson is CEO and Co-Founder of Dash Bio and former Chief Data & AI Officer at Moderna. He’s pioneering automation in clinical bioanalysis to accelerate drug development.
Wolfgang Halter leads Data Science at Merck Life Science, developing tools like BayBE to optimize R&D through smarter data modeling and open-source innovation.
Jacob Oppenheim is a Venture Partner at RAVen and co-founder of Fresnel. With a PhD in Biological Physics, he champions the transition to digital-native biopharma.
About The Host
Ross Katz is Principal and Data Science Lead at CorrDyn. Ross specializes in building intelligent data systems that empower biotech and healthcare organizations to extract insights and drive innovation.
Connect with Our Guest:
Connect with Us:
Sponsored by…
This episode is brought to you by CorrDyn, the leader in data-driven solutions for biotech and healthcare. Discover how CorrDyn is helping organizations turn data into breakthroughs at CorrDyn.

32,011 Listeners

7,588 Listeners

4,161 Listeners

112,236 Listeners

56,509 Listeners

125 Listeners

322 Listeners

4,753 Listeners

33 Listeners

517 Listeners

2,067 Listeners

5,509 Listeners

146 Listeners

18 Listeners

44 Listeners